Dr. Jim Xiang awarded a Saskatchewan Cancer Agency Grant
Dr. Jim Xiang was awarded a 2-year grant from the Saskatchewan Cancer Agency. Title: ‘Therapeutic immunity of heterologous HER2-specific HuRt-Texo vaccination against trastuzumab-resistant breast cancer in BLT/NSG humanized mice.’